title: Selective depletion of major and minor histocompatibility antigen reactive T cells: towards prevention of acute graft-versus-host disease.
abstract: Development of acute graft-versus-host disease (aGVHD) following HLA-identical sibling bone marrow transplantation (BMT) remains a serious complication. A selective depletion of T cells has proved to be effective in preventing aGVHD but is associated with relapse and increased incidence of infection. As aGVHD is directed mainly against epithelial tissues we examined whether it would be feasible to selectively deplete T cells reactive with epithelial cells whilst preserving other specificities. Donor T cells which express HLA-DR, CD25, CD69 and CD71 activation markers after cocultivation with patient keratinocytes were depleted using magnetic cell separation techniques. Depletion of major as well as minor histocompatibility antigen activated T cells revealed a significant (P = 0.004 and P = 0.031, respectively) 10-fold decrease in the frequency of donor T lymphocyte precursors reactive with patient keratinocytes. The frequency reactive with third-party and patient peripheral blood mononuclear cells, including leukaemia cells, remained unchanged, supporting the notion that aGVHD and graft-versus-leukaemia (GVL) may be separable. This alloantigen-specific depletion may be used in matched unrelated as well as HLA-identical sibling BMT for reducing aGVHD whilst conserving GVL.
authors.affiliation: Jordan Laboratory, Department of Immunohaematology, University Hospital Utrecht, The Netherlands. a.m.c.vandijk@lab.azu.nl
authors.forename: A M
authors.initials: AM
authors.lastname: van Dijk
authors.forename: F L
authors.initials: FL
authors.lastname: Kessler
authors.forename: S A
authors.initials: SA
authors.lastname: Stadhouders-Keet
authors.forename: L F
authors.initials: LF
authors.lastname: Verdonck
authors.forename: G C
authors.initials: GC
authors.lastname: de Gast
authors.forename: H G
authors.initials: HG
authors.lastname: Otten
mesh_terms: D000328:Adult; D002460:Cell Line; D006086:Graft vs Host Disease / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D008212:Lymphocyte Depletion; D008285:Major Histocompatibility Complex / Q000276:immunology*; D008875:Middle Aged; D015778:Minor Histocompatibility Antigens / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D015778:Minor Histocompatibility Antigens